TABLE 3.
Means (SD) of adherence and HRQoL against characteristics of PWE.
| Variables | Suboptimally adherent (n, %) | Adherent (n, %) | p Values | HRQoL (overall weighted mean score) | p Values |
|---|---|---|---|---|---|
| Gender a | <.001 | <.001 | |||
| Male | 47 (26.0) | 69 (56.9) | 63.7 (± 16.8) | ||
| Female | 67 (65.0) | 36 (34.9) | 51.4 (± 17.3) | ||
| Age groups b | <.001 | <.001 | |||
| 18–25 | 27 (82.0) | 45 (62.5) | 55.8 (± 14.7) | ||
| 26–45 | 51 (48.1) | 55 (51.9) | 52.5 (± 17.1) | ||
| >46 | 30 (73.1) | 11 (26.8) | 41.7 (± 17.1) | ||
| Education level b | <.001 | <.001 | |||
| Less than primary education | 16 (80.0) | 4 (20.0) | 42.8 (± 18.9) | ||
| Primary | 6 (66.6) | 3 (33.3) | 44.1 (± 17.1) | ||
| Secondary | 86 (46.5) | 99 (53.5) | 52.6 (± 16.6) | ||
| Tertiary | 0 | 5 (100) | 63.6 (± 2.40) | ||
| Marital status a | |||||
| Single | 78 (54.2) | 66 (45.8) | 49.3 (± 17.5) | ||
| Married/in relationship | 30 (40.0) | 45 (60.0) | 56.0 (± 15.1) | ||
| Easy to afford medicines? a | .08 | .07 | |||
| Yes | 48 (38.1) | 78 (61.9) | 56.7 (± 14.7) | ||
| No | 60 (64.5) | 33 (35.5) | 44.7 (± 17.6) | ||
| Duration of Epilepsy b | <.001 | <.001 | |||
| <5 years | 64 (42.4) | 87 (57.6) | 53.7 (± 16.7) | ||
| 5–10 years | 26 (66.7) | 13 (33.3) | 47.5 (± 16.3) | ||
| >10 years | 18 (62.1) | 11 (37.9) | 46.1 (± 18.1) | ||
| Antiepileptic drugs a | <.001 | <.001 | |||
| Monotherapy | 19 (13.6) | 121 (86.4) | 52.8 (± 16.4) | ||
| Combination therapy | 18 (22.8) | 61 (77.2) | 49.4 (± 17.9) |
a
Independent samples t‐test.
b
One way ANOVA.